Contact Locum Whats New at Locum IAGIM - The International Association of Generic and Innovative Drug Manufacturers Home Page Download Your Resources Here Online Ordering

Official Conference Sponsor :


  Legal and Commercial Strategies for Combatting Generics in Pharmaceuticals
18 January '00 - Day 1
08:00 Registration and coffee

08:30 Opening remarks by the chair
Dr. Michael L. Burstall
Consultant

08:45 Quantifying the economic aspect of generics in Europe - how does the increased competition from generic drugs affect healthcare and research spending?
Dr. Michael L. Burstall
Consultant

09:30 The future of generics and reference pricing in Europe and its implications for the industry
Jim Furniss
Management Consultant
Cambridge Pharma Consultancy

10:15 Morning tea and coffee

10:35 Regulation and Market Development or Generics in the United Kingdom
Donald Macarthur
Consultant

11:20 Regulation and market development of generics in Germany
Wilhelm Hollenhorst
Special Adviser, Healthcare System Develpment
German Association of Research

12:05 Impact of CEE accession on research based companies and generic competition
Simon Harper
Senior Assistant Solicitor
Lovell White Durrant

12:50 Lunch

14:00 Analysing your most promising strategies to exploit and extend patent protection in Europe
Stephen Jones
Partner
Baker & McKenzie

14:45 Development and registration strategies which give advantage to your branded products over generic competition
Horst Kastrup
Head of Drug Regulatory Affairs
Asta medica

15:45 Afternoon tea and coffee

16:05 A viewpoint from the generic pharmaceutical industry
Greg Perry
Director General
European Generics Association

16:05 Debating legal and commercial options to manage generic competition and its impact on pharmaceutical companies
Horst Kastrup
Head of Drug Regulatory Affairs
Astra Medica

16:50 Debating legal and commercial options to manage generic competition and its impact on pharmaceutical companies
Greg Perry
Director General
European Generics Association

16:50 Debating legal and commercial options to manage generic competition and its impact on pharmaceutical companies
Wilhelm Hollenhorst
Special Adviser, Healthcare System Development
Verband Forschender Arzneimettelhersteller

17:20 Closing remarks by the chair

17:35 End of Day 1


  Legal and Commercial Strategies for Combatting Generics in Pharmaceuticals
19 January '00 - Day 2
08:30 Registration and coffee

09:00 Opening remarks by the chair
Dr Gordon Wright
Director, Intellectual Property
Sanofi-Synthelabo

09:15 Maximising the benefits of data exclusivity to defend your product successfully
Dr Christoph Hiltl
Partner
Boesebeck & Droste

10:00 New Zealand today, Europe tomorrow? - The New Zealand Generics Programme
Gisela Brinkmeier
Director, International Marketing
G. Pohl-Boskamp

10:45 Morning tea and coffee

11:05 Defensive pricing strategie to limit damage from generic competition - is there a way that industry can leverage brand value
Dr Jim Attridge
Government and Economic Affairs
AstraZeneca

11:50 Pros and cons of entering into the generics market
Norbert Bangert
Manager Generics
Bayer

12:35 Lunch for delegates and speakers

13:45 Analysing the latest developments in US regulation of generics and their effects in Europe
Richard Kingham
Managing Partners
Covington & Burling London

14:30 Clarifying the impact of the Farmitalia Carlo Erba v German patent office and BASF cases on Supplementary Protection Certificates
Lorna Brazel
Senior IP solicitor
Bird & Bird

15:15 Devising the most appropriate marketing strategies to increase the margin of your branded products and succeed in the emerging new marketplace
Paul Jones
Principal Consultant
PriceWaterhouseCoopers

16:00 Closing remarks by the chair

16:15 Join us for tea and coffee to review the findings of the conference

16:35 End of Conference


  Legal and Commercial Strategies for Combatting Generics in Pharmaceuticals
20 January '99 - Workshop
08:30 Brief outline by the workshop leaders on the issue to be dealt with during the workshop and presentation of the studies, 2 Case Studies

16:30 Review and Conclusions



Official Publication and Sponsor
International Journal of Generic Drugs.
For Additional Details Contact Locum International
www.locumUsa.com
www.locumEuro.com
www.locum.co.il
Fax : +972-97-494-532


Other Publications


HOME


WELCOME | JOURNALS | HANDBOOKS | IAGIM | IAGIM ONLINE | What's NEW | CONTACT | LINKS
BOOKSTORE | DOWNLOAD AREA | ARTICLE of the MONTH
| SPECIAL OFFERS | FAQ | CONFERENCES
WORLDWIDE SITES | DRUG DEVELOPMENT WORK SHOPS | JOBS | CLIENT PROFILE


CONTACT | info @ LocumUSA . com |
© 1992-2015/16 Locum International Group. - All Rights Reserved. Web Design by TheBookShop - A Division of the LIGroup